Evolus, Inc. financial data

Symbol
EOLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
520 Newport Center Drive, Suite 1200, Newport Beach, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 259 % +17.4%
Quick Ratio 27.1 % -41.8%
Debt-to-equity -35.6K % -2705%
Return On Equity 9.25K %
Return On Assets -26.1 % +31.3%
Operating Margin -16.3 % +50.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.1M shares +10.7%
Common Stock, Shares, Outstanding 63.1M shares +10.7%
Entity Public Float 405M USD -4.42%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 62.7M shares +10.2%
Weighted Average Number of Shares Outstanding, Diluted 62.7M shares +10.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 237M USD +40.7%
Research and Development Expense 1.69M USD -17.8%
Costs and Expenses 276M USD +23%
Operating Income (Loss) -38.7M USD +30.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -53M USD +20%
Income Tax Expense (Benefit) 220K USD +91.3%
Net Income (Loss) Attributable to Parent -53.2M USD +19.8%
Earnings Per Share, Basic -0.9 USD/shares +23.7%
Earnings Per Share, Diluted -0.9 USD/shares +23.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.7M USD +125%
Accounts Receivable, after Allowance for Credit Loss, Current 43.1M USD +48.8%
Inventory, Net 13.4M USD -32.6%
Other Assets, Current 2.43M USD +51.3%
Assets, Current 158M USD +63.9%
Property, Plant and Equipment, Net 2.28M USD -2.93%
Operating Lease, Right-of-Use Asset 5.46M USD +259%
Intangible Assets, Net (Excluding Goodwill) 46.3M USD -1.99%
Goodwill 21.2M USD 0%
Other Assets, Noncurrent 409K USD +83.4%
Assets 234M USD +38.3%
Accounts Payable, Current 10.3M USD +31.2%
Employee-related Liabilities, Current 8.35M USD +26.5%
Accrued Liabilities, Current 32.8M USD +35.6%
Contract with Customer, Liability, Current 11.8M USD +31.9%
Liabilities, Current 54.1M USD +30.9%
Deferred Income Tax Liabilities, Net 29K USD +31.8%
Operating Lease, Liability, Noncurrent 4.79M USD +642%
Liabilities 214M USD +21.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -601K USD -28.4%
Retained Earnings (Accumulated Deficit) -583M USD -10%
Stockholders' Equity Attributable to Parent 19.3M USD
Liabilities and Equity 234M USD +38.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +48.4%
Net Cash Provided by (Used in) Financing Activities 45.7M USD
Net Cash Provided by (Used in) Investing Activities -797K USD -56%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 63.1M shares +10.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 34.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.7M USD +125%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.42M USD
Deferred Tax Assets, Valuation Allowance 116M USD +11.9%
Operating Lease, Liability 5.83M USD +192%
Payments to Acquire Property, Plant, and Equipment 256K USD +12.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -53.3M USD +20%
Lessee, Operating Lease, Liability, to be Paid 7.97M USD +270%
Operating Lease, Liability, Current 1.04M USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.45M USD +1162%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD -23.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +21.3%
Deferred Income Tax Expense (Benefit) 5K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.14M USD +1235%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.5M USD
Deferred Tax Assets, Operating Loss Carryforwards 83.3M USD +3.43%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.92M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD
Additional Paid in Capital 603M USD +15.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4.43M USD +20.2%
Depreciation, Depletion and Amortization 5.52M USD +25.6%
Deferred Tax Assets, Net of Valuation Allowance 9.16M USD -25.8%
Share-based Payment Arrangement, Expense 19.9M USD +60.6%
Interest Expense 15.7M USD +60%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%